Tirzepatide 50mg Kit of 10

Tirzepatide is a cutting-edge dual incretin agonist that mimics both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — two key hormones involved in regulating blood sugar, satiety, and energy balance. This unique mechanism allows for enhanced appetite suppression, improved insulin sensitivity, and significant fat loss when combined with proper nutrition and lifestyle protocols.
Available as a lyophilized powder, Tirzepatide requires reconstitution prior to use.

Usage Info

Tirzepatide
Dual GLP-1/GIP Receptor Agonist | Advanced Injectable for Weight Management & Metabolic Support
Overview:
Tirzepatide is a cutting-edge dual incretin agonist that mimics both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) — two key hormones involved in regulating blood sugar, satiety, and energy balance. This unique mechanism allows for enhanced appetite suppression, improved insulin sensitivity, and significant fat loss when combined with proper nutrition and lifestyle protocols.
Available as a lyophilized powder, Tirzepatide requires reconstitution prior to use.

 
Key Benefits:
• Dramatically reduces hunger and cravings
• Promotes significant and sustainable weight loss
• Improves glucose regulation and insulin efficiency
• Once-weekly subcutaneous injection for ease of use
• Supports cardiometabolic health markers (A1C, triglycerides, blood pressure)

 
Reconstitution Instructions:
• Reconstitute with Bacteriostatic Water (BAC)
• Example: Add 2mL of BAC to a 5mg vial to yield 2.5mg/mL
• Gently swirl (do not shake) until fully dissolved
• Store reconstituted Tirzepatide in the refrigerator (2–8°C)
• Use within 28 days
Need help with dosage or reconstitution math?
Use our [Reconstitution Calculator] on the website to customize your solution and dosing schedule.

 
Dosing Guidelines:
• Start at 2.5mg weekly, titrate upward gradually
• Therapeutic range: 5mg–15mg per week, depending on goals and tolerance
• Administer subcutaneously in the abdomen, thigh, or upper arm
• Duration of use: 12–24+ weeks based on results and clinical response

 
Monitoring & Considerations:
• Common side effects: Mild nausea, early satiety, constipation, or fatigue (typically temporary)
• Monitor: Blood sugar, hydration, and gastrointestinal tolerance
• Not suitable for individuals with a personal/family history of medullary thyroid carcinoma (MTC) or MEN2 syndromes

 
Note: Tirzepatide is a powerful tool for transforming body composition, especially when paired with structured nutrition, regular movement, and long-term metabolic support strategies. For best results, use under professional guidance with consistent tracking.